期刊文献+

静脉大剂量糖皮质激素治疗甲状腺相关眼病疗效观察 被引量:5

The observation of high dose intravenous glucocorticold in treating thyroid associated ophthalmopathy
下载PDF
导出
摘要 目的观察大剂量糖皮质激素治疗甲状腺相关眼病的疗效。方法对56例甲状腺相关眼病患者,给予静脉滴注甲基强的松龙500mg/d,连续3d,间隔4d。第2周再静脉用药3d后改口服强的松,40mg/d,每周递减5~10mg,直至5mg/d,维持l~2个月。结果 50例临床症状明显改善,有效率89.2%。结论大剂量糖皮质激素治疗甲状腺相关眼病疗效满意。 Objective To observe the outcome of high dose corticosteroid therapy in thyroid-associated ophthalmopathy (TAO), Methods Methylprednisolone was intravenous to 56 cases with TA0,500 mg/d for 3 days and stopped for 4 days in the first week, and same in the second week, then used prednisone 40 mg/d, re- duced 5 ~ 10 mg every week, till 5 mg/d, remained 2 months. Results 50 cases'clinical symptoms were im- proved, the efficient rate was 89. 2%. Conchtsion High dose intravenous glucocorticold can effectively improve the symptoms and signs of thyroid associated ophthalmopathy.
作者 石韶宇 刘芳
出处 《中国实用医药》 2013年第10期52-53,共2页 China Practical Medicine
关键词 甲状腺相关眼病 糖皮质激素 Thyroid associated ophthalmopathy Corticosteroid
  • 相关文献

参考文献5

二级参考文献28

  • 1刘春玲,罗清礼,吕红彬.甲状腺相关眼病眼眶组织病理学研究[J].四川大学学报(医学版),2005,36(3):436-437. 被引量:16
  • 2傅德生,许雪亮.CD40-CD40L与甲状腺相关眼病[J].国际眼科杂志,2006,6(1):183-187. 被引量:10
  • 3陈敏,周翔天,盛文,瞿佳.甲状腺相关性眼病研究治疗新进展[J].国际眼科杂志,2006,6(4):875-878. 被引量:23
  • 4Ali Sadeghi Tari,Mohammad Taher Rajabi,Khalil Hamzedust,Seyed Ziaeddin Tabatabaie,Abolfazl Kasai.伊朗Graves眼病的临床特点(英文)[J].国际眼科杂志,2007,7(2):322-326. 被引量:3
  • 5Gracia-Naya M,Uson M,Lopez-Lopez A,et al.Thyroid ophthalmopathy ad a unique clinical manifestation of thyrotoxicosis.Rev Neurol,1995,23:1059-1062.
  • 6Osher RH,Smith JL.Ocular myasthenia gravis and Hashimoto′s thyroiditis.Am J Ophthalmol,1975,79:1038-1043.
  • 7Cathelineau G,Fribourg-Desi M.Graves-Basedow type ophthalmopathy and primary hypothyroidism.Nouv Presse Med,1974,3:1995-1998.
  • 8Marcccci C,Mareino M,Rocchi R,et al.Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy:the first European Group on Graves' Orbitopathy experience[ J].Eur J Endocrinol,2003,148(5):491-495.
  • 9Bartalena L,Pinchera A,Marcocci C.Management of Graves' ophthalmopathy:reality and perspectives[ J ].Endocr Rev,2000,21 (2):168-199.
  • 10Bartalena L,Marcocci C,Tanda ML,et al.An update on medical management of Graves' ophthalmopathy[ J ].J Endocrinol Invest,2005,28(5):469-478.

共引文献22

同被引文献46

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部